CME Group Inc.

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, SPGI has a market cap of 127.9B. Regarding current trading prices, CME is priced at $311.40, while SPGI trades at $422.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas SPGI's P/E ratio is 29.22. In terms of profitability, CME's ROE is +0.14%, compared to SPGI's ROE of +0.14%. Regarding short-term risk, CME is less volatile compared to SPGI. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check SPGI's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, ICE has a market cap of 90.8B. Regarding current trading prices, CME is priced at $311.40, while ICE trades at $159.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas ICE's P/E ratio is 27.64. In terms of profitability, CME's ROE is +0.14%, compared to ICE's ROE of +0.12%. Regarding short-term risk, CME is less volatile compared to ICE. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check ICE's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, MCO has a market cap of 76.2B. Regarding current trading prices, CME is priced at $311.40, while MCO trades at $430.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas MCO's P/E ratio is 31.41. In terms of profitability, CME's ROE is +0.14%, compared to MCO's ROE of +0.63%. Regarding short-term risk, CME is less volatile compared to MCO. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check MCO's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, COIN has a market cap of 52.7B. Regarding current trading prices, CME is priced at $311.40, while COIN trades at $195.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas COIN's P/E ratio is 43.55. In terms of profitability, CME's ROE is +0.14%, compared to COIN's ROE of +0.09%. Regarding short-term risk, CME is less volatile compared to COIN. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check COIN's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, NDAQ has a market cap of 48.8B. Regarding current trading prices, CME is priced at $311.40, while NDAQ trades at $85.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas NDAQ's P/E ratio is 27.68. In terms of profitability, CME's ROE is +0.14%, compared to NDAQ's ROE of +0.15%. Regarding short-term risk, CME is less volatile compared to NDAQ. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check NDAQ's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, MSCI has a market cap of 41.2B. Regarding current trading prices, CME is priced at $311.40, while MSCI trades at $547.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas MSCI's P/E ratio is 34.93. In terms of profitability, CME's ROE is +0.14%, compared to MSCI's ROE of -0.75%. Regarding short-term risk, CME is less volatile compared to MSCI. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check MSCI's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, CBOE has a market cap of 30.4B. Regarding current trading prices, CME is priced at $311.40, while CBOE trades at $290.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas CBOE's P/E ratio is 27.85. In terms of profitability, CME's ROE is +0.14%, compared to CBOE's ROE of +0.23%. Regarding short-term risk, CME is less volatile compared to CBOE. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check CBOE's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, FDS has a market cap of 7.7B. Regarding current trading prices, CME is priced at $311.40, while FDS trades at $205.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas FDS's P/E ratio is 13.09. In terms of profitability, CME's ROE is +0.14%, compared to FDS's ROE of +0.28%. Regarding short-term risk, CME is less volatile compared to FDS. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check FDS's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, MORN has a market cap of 7.5B. Regarding current trading prices, CME is priced at $311.40, while MORN trades at $183.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas MORN's P/E ratio is 21.23. In terms of profitability, CME's ROE is +0.14%, compared to MORN's ROE of +0.25%. Regarding short-term risk, CME is less volatile compared to MORN. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check MORN's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, DNB has a market cap of 4.1B. Regarding current trading prices, CME is priced at $311.40, while DNB trades at $9.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas DNB's P/E ratio is -101.67. In terms of profitability, CME's ROE is +0.14%, compared to DNB's ROE of -0.01%. Regarding short-term risk, CME is more volatile compared to DNB. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check DNB's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, VALU has a market cap of 348.5M. Regarding current trading prices, CME is priced at $311.40, while VALU trades at $37.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas VALU's P/E ratio is 16.42. In terms of profitability, CME's ROE is +0.14%, compared to VALU's ROE of +0.21%. Regarding short-term risk, CME is less volatile compared to VALU. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check VALU's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 112B. In comparison, BTOG has a market cap of 3.8M. Regarding current trading prices, CME is priced at $311.40, while BTOG trades at $2.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.90, whereas BTOG's P/E ratio is -0.15. In terms of profitability, CME's ROE is +0.14%, compared to BTOG's ROE of -6.75%. Regarding short-term risk, CME is less volatile compared to BTOG. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check BTOG's competition here